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Monoclonal antibodies (mAB) have been produced which recognize the physiologically active 2-cis-(S)-form 
of the endogenous plant growth regulator, abscisic acid (ABA). Cross-reaction with the ABA-catabolites, 
phaseic and dihydrophaseic acid, is negligible, and (R)-ABA, 2-trans-ABA, the ABA-conjugate, 
ABA-P-D-glucopyranosyl ester, as well as the putative ABA precursor, xanthoxin, are totally unreactive. 
In addition to being very specific, the mAB exhibit high affinities for 2-cis-@)-ABA: the K values were 
7.9 x lo9 l/m01 and 3.7 x lo9 l/m01 for antibodies from two different clones. By mAB-radioimmunoassay 
(RIA), 4pg of 2-cis-@)-ABA (99.5% confidence level) can be detected. mAB-RIA can be used to 
quantitate ABA directly in unprocessed plant extracts. 
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1. INTRODUCTION 
The endogenous plant growth regulator, abscisic 
acid (ABA), is thought to be involved in the regula- 
tion of a multitude of developmental processes 
such as growth inhibition, fruit and leaf abscission, 
bud and seed dormancy or senescence acceleration 
[l]. Furthermore, it appears to be a central factor 
in the defense to water stress in plants, in that it 
triggers stoma&l closure 121. The physiological 
functions of ABA, its intracellular distribution and 
its mode of action are under intensive investiga- 
tion. The practical importance of ABA is amply 
shown by the fact that improvement of drought 
tolerance in major crop species is being attempted 
by altering the ABA economy of plants [2]. Crucial 
to such studies is the availability of an efficient 
tool for the detection and quantitation of ABA 
present in tissues in physiological concentrations 
(1O-8-1O-6 M). 
Abbreviations: ABA, abscisic acid; ABAG, ABA&D- 
glucopyranosyl ester; DP, dihydrophaseic acid; FCS, 
fetal calf serum; mAB, monoclonal antibodies; PA, 
phaseic acid, pAB, polyclonal antibodies; RIA, radio- 
immunoassay, TLC, thin layer chromatography 
With the availability of radio-(RIA) and enzyme 
immunoassay (EIA) techniques based on poly- 
clonal antibodies (pAB) [3-71, the analysis of 
ABA in plant material has been greatly simplified. 
However, the inevitable presence in these antisera 
of low-affinity antibodies and the resulting cross- 
reactivities preclude the use of pAB in studies of 
intracellular localization of ABA, and may limit 
the use of immunoassay for the quantitative ana- 
lysis of ABA in the presence of high levels of ABA 
precursors, ABA catabolites or conjugates. These 
drawbacks of pAB should be overcome by the use 
of mAB. However, mAB exhibiting both high 
specificity and selectivity would be required; to 
date these have only rarely been obtained for low- 
A4 compounds [8-lo]. 
* To whom correspondence should be addressed 
Here, we report the production and characteri- 
zation of mAB against ABA which exceed pAB in 
both affinity and selectivity. These results open 
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new possibilities in the detection and determina- 
tion of ABA in particular and other plant growth 
regulators and low-M, plant constituents in general. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Cells were cultured in RPM1 1640 (Gibco) with 
10% fetal calf serum (FCS) (Roth), 1OOU penicil- 
lin/ml and 1OOpg streptomycin/ml. To support 
growth of hybridoma cells, the medium was sup- 
plemented with MEM-non-essential amino acids 
(1 x , Gibco) and 1 mM sodium pyruvate (Gibco). 
2.2. Antigen and immunization 
The antigen was synthesized by reacting 2-c& 
(R, S)-ABA4’-tyrosylhydrazone with p-aminohip- 
puric acid-substituted bovine serum albumin [S]. 
The antigen (2OOpg/animal) was dissolved in 0.2 ml 
PBS (0.1 M Na-phosphate, 0.15 M NaCl) and emul- 
sified in an equal volume of complete Freund’s 
adjuvant (Difco). Antigen was administered i.p. to 
&week-old female Balb/c mice. Booster injections 
with, per animal, 200,ug antigen in incomplete 
Freund’s adjuvant were given i.p. 1, 2, 4, 5, 7 and 
8 weeks after the first injection. A final booster in- 
jection (2OOpg antigen in 0.3 ml PBS/animal) was 
given i.v./i.p. on week 13, 4 days prior to cell fu- 
sion. Controls of serum antibody titers were ob- 
tained by RIA, using blood taken from the retro- 
orbital system. 
2.3. C&l fusion and cloning 
For the cell fusions, the 8azaguanine resistant 
Balb/c MOPC 21 derived myeloma line P3-NSl- 
AG4-1 (NSl) [ll], provided by V. Fantl, London 
Imperial Cancer Research Fund, was used. The 
protocol for cell fusion is based on [12]. After 
removal of the spleen from a sacrificed animal, 
7 x 10’ spleen cells and 1.8 x 10’ myeloma cells 
were fused in the presence of polyethylene glycol 
1500 (Roth, 50% w/v, at 37’C, 1.5 min, 1 ml). 
After fusion, the cells were distributed in 24-well 
Costar trays (Nunc) and cultured in RPM1 1640 
containing HAT (H, hypoxanthine; A, aminop- 
terine; I, thymidine) and 20% FCS. To support the 
growth of hybrids, each well had been incubated 
with 4 x lo4 peritoneal cells from non-immunized 
Balb/c mice the day before. The incubation medium 
was not changed until growth of cell clones became 
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apparent. Aliquots of the supernatants were re- 
moved and examined for the presence of antibodies 
against ABA by RIA. Positive clones were, then, 
supplemented with fresh medium containing HT, 
every 3-4 days until the bottom of the wells was 
nearly covered with cells. These were, then, trans- 
ferred to 50ml culture flasks. 
Cloning of hybrid cells was done twice by limiting 
dilution [12] in 96-well Costar trays with 0.75 
cells/well. After cloning, cells were adapted to 
grow in the absence of HT, harvested, frozen in 
RPM1 1640 with 20% FCS and 10% dimethylsul- 
foxide and stored in liquid nitrogen. Ascites fluid 
was produced by injecting Balb/c mice with 0.5 ml 
pristane (Aldrich) i.p. 6 days prior to the i.p. injec- 
tion of 1.5 x lo6 hybridoma cells. 
2.4. Double immunodiffsion 
The Ouchterlony technique [13] was used to 
determine the immunoglobulin class of the secreted 
mAB, using rabbit anti-mouse Fab (Nordic), IgGl, 
IgG2a, IgG2b, IgA and IgM (Bionetics) as probes. 
2.5. Radioimmunoassay 
Antibody titration, cross-reactivity determina- 
tions and ABA quantitation were performed by 
RIA as in [5], with 2-cis-(R,S)-[3H]ABA (39 Ci/ 
mmol, Amersham) as radiotracer. 
3. RESULTS 
3.1. Cell fusion and cloning 
Growth of cell hybrids was detected 8 days after 
fusion. At this time, microscopic examination 
showed growing cells in every well (l-5 colonies/ 
well). Supernatants from 16 wells (8.3%) initially 
showed ABA binding capacity which was later lost 
in 10 wells. From the remaining, 4 stable cell lines 
were derived by cloning. Ascites fluid was pro- 
duced from 2 of the lines. These clones (16-I-A4 
and 16-I-C5) were characterized further. By double 
immunodiffusion [13], 16-I-C5 was shown to 
secrete IgGr, whereas 16-I-A4 secretes IgA. 
3.2. Antibody affinity, specificity and sensitivity 
of mAB-RIA 
Antibody affinity for 2-cis-@)-ABA was calcu- 
lated from Langmuir plots: K = 7.88 x 10gl/mol 
(16-I-A4) and K = 3.69 x lO’l/mol (16-I-C5). 
Titers of mAB in ascites fluids were 1 : 396000 
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(16-I-A4) and 1: 450000 (16-I-CS) (final dilutions 
binding 30% of 0.2 pmol 2-c&(S)-[3H]ABA). Stan- 
dard curves (fig.1) for 2-cis-@)-ABA defined a 
measuring range of mAB-RIA between 5-1000 pg 
(16-I-A4), the detection limit being 4 pg (15 fmol) 
at the 99.5% confidence level. 
A cross-reactivity study of both mAB (table 1) 
revealed the high degree of selectivity for the 
physiologically active [14] 2-cis-@)-ABA. Both the 
R-enantiomers and the 2-trans isomer were non- 
immunoreactive. The predominant ABA-conju- 
gate in plants, ABA-,8-D-glucopyranosyl ester 
(ABAG), the ABA catabolites, phaseic (PA) and 
dihydrophaseic (DPA) acid and the putative ABA 
precursor, xanthoxin, were either non-immuno- 
reactive (ABAG, xanthoxin) or over lOOO-fold less 
reactive (PA, DPA). In TLC fractions of unpuri- 
fied plant extracts, only the 2-&ABA zone showed 
immunoreactivity which excludes unknown inter- 
fering material and documents that 2-cis-@)-ABA 
can be determined directly in unpurified plant ex- 
tracts (fig.2). 
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Fig. 1. Typical standard-curve for the mAB-RIA of 2-c&- 
(S)-ABA. Assays were performed according to [5]. Bars 
represent *SD of triplicate standards. B = binding of 
~-c~~-(S)-[~H]ABA in the presence of unlabeled antigen 
(Bo, binding in the absence of unlabeled antigen). The 
insert shows the linearized logit/log plot of the data 
(logit B/B0 = ln[B/Bo/(lOO - B/Bo)J). 
Table 1 
Specific of mAB raised against 2-cis-@)-ABA 
Compound Clone 16-I-A4 Clone 16-I-C5 
2-cis-(S)-ABA 100 100 
2-cis-(S)-ABA methyl 
ester <O.l <O.l 
2-cis-(R)-ABA 0 0 
2-trans-(S)-ABA 0 0 
2-cis-(S)-ABA-&D- 
glucopyranosyl ester 0 0 
2-cis-(S)-ABA-cis-diol 0 0 
Phaseic acid co.1 <O.l 
Dihydrophaseic acid <O.l co.1 
Xanthoxin 0 0 
All-trans-Farnesol 0 0 
The data are cross-reactions in % on molar basis. They 
were calculated at 50% displacement from radiotracer- 
displacement curves run for each compound, assigning 
2-cis-(S)-ABA the relative value of 100% 
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Fig.2. Distribution of immunoreactive material on thin- 
layer chromatograms (TLC) of methanolic extracts of 
Vicia faba L. leaves (black bars, unstressed; open bars, 
water-stressed by allowing detached leaves to wilt for 
24 h at ambient temperature). Leaf tissue (0.7 g) was ex- 
tracted and processed as in [5] (TLC, silgel; solvent, 
toluene-ethyl acetate-acetic acid = 50: 30: 4, by vol.). 
To indicate the degree of impurity of the extracts, A260 
was recorded in all fractions (. . a). DW, dry weight; 
1, ABAG and conjugates of PA, DPA; 2, DPA; 3, 
xanthoxin; 4, PA; 5, 2-cis-ABA; 6, 2-trans-ABA. 
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4. DISCUSSION 
A critical factor in developing mAB for low-M, 
antigens is the selection of hybridoma clones com- 
bining a high degree of specificity with high af- 
finity. The mAB producing clones reported here 
fulfill these requirements and are superior to the 
pAB hitherto available for ABA [3-71. The binding 
area of the mAB to ABA includes all positions 
relevant for physiological activity of the molecule. 
As becomes evident from table 1, structurally and 
biogenetically related compounds, the 2-tram iso- 
mer of ABA and even the (R)-enantiomer show 
very little or no cross-reactivity. These compounds 
would thus not interfere with ABA determination, 
even in situations of increased ABA-metabolism 
(fig.2), and even if they occur in large excess. 
mAB-RIA now allows a very convenient quantita- 
tion of low levels of the physiologically active form 
of ABA in unprocessed plant extracts. This renders 
mAB-RIA a powerful tool in studies on general 
ABA-physiology as well as in attempts to improve 
drought resistance of crop plants by genetically or 
chemically altering their ABA-economy. The mAB 
now available should also be extremely useful to 
study the intracellular localization of ABA and 
should provide a convenient means of resolution 
or racemic mixtures of synthetic radiolabeled ABA 
for metabolic studies. 
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